Abstract

Background The efficiency of migraine therapy depends on it’s comorbidities. One of these co-morbidities is represented by undifferentiated connective tissue dysplasia (UCTD). In general population the joint hypermobility syndrome (JHS) may be present in 5-30% (Murray K.J., 2001) and minor congenital heart defects (MCHDs) in 5-35% (Freed L.A., 1999). In adults approximately 75% of patients with JHM suffer migraine (Bendik E.M., 2011).

Highlights

  • The efficiency of migraine therapy depends on it’s comorbidities. One of these co-morbidities is represented by undifferentiated connective tissue dysplasia (UCTD)

  • In adults approximately 75% of patients with JHM suffer migraine (Bendik E.M., 2011)

  • Aim To study the manifestations of joint hypermobility syndrome (JHS) and minor congenital heart defects (MCHDs) in children and adolescents with migraine compared with their peers suffering tension-type headache (TTH)

Read more

Summary

Introduction

The efficiency of migraine therapy depends on it’s comorbidities. One of these co-morbidities is represented by undifferentiated connective tissue dysplasia (UCTD). The prevalence of undifferentiated connective tissue dysplasia syndrome in children with migraine From 4th European Headache and Migraine Trust International Congress: EHMTIC 2014 Copenhagen, Denmark.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call